Search

everythinglearnresearchcommunity

for

Search:↓

Baricitinib improves quality of life and reduces anxiety and depression in severe alopecia areata patients with hair regrowth.

Baricitinib effectively regrows hair in most people with severe alopecia, especially those with patchy hair loss, but hair may fall out again if treatment stops.

Baricitinib was effective and safe for severe hair loss treatment over 6 months.

Ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata.

Tofacitinib is effective and safe for treating severe alopecia areata and related conditions.

Methotrexate sometimes helps regrow hair in children with severe alopecia areata and is generally safe.

Certain blood miRNAs are linked to severe alopecia areata and could lead to new treatments.

Ritlecitinib may be more effective for severe alopecia areata than conventional treatments.

Hair loss is a frequent long-term effect of COVID-19, and oral minoxidil is the most common effective treatment.

CD8+ T cells re-expressing CD45RA may predict treatment resistance in severe alopecia areata.

Ruxolitinib effectively regrows hair in most patients with severe hair loss.

The combined therapy was effective and safe for children with severe alopecia areata.

High-dose steroid pulse therapy effectively regrows hair in severe multifocal alopecia areata.

High and low doses of prednisolone helped 62% of children with severe alopecia regrow hair with some weight gain and mild acne as side effects.

Wigs significantly improve the well-being of people with severe hair loss.

High-dose corticosteroids and methotrexate had a modest effect on severe childhood alopecia, but side effects and relapse were concerns.

Both individual and combined treatments of tofacitinib and corticosteroids can help regrow hair in moderate-to-severe alopecia areata, but ongoing treatment may be necessary.

JAK inhibitors do not increase cancer risk in severe alopecia areata compared to traditional treatments.

COVID-19 vaccines may rarely worsen hair loss in people with severe alopecia, but the benefits of vaccination still outweigh this risk.

Mini pulse corticosteroid therapy with oral dexamethasone is effective and has fewer side effects for treating extensive alopecia areata.

Increasing the dose of baricitinib to 4 mg helps more patients with severe alopecia areata regrow hair.

Platelet-rich plasma treatment is not very effective for chronic severe alopecia areata.

IMG-007 helps regrow hair and reduce scalp inflammation in severe alopecia areata.

Switching Janus kinase inhibitors helped some patients with severe alopecia areata regrow hair, but insurance issues can worsen the condition.

Alopecia Areata severely impacts mental health, causing anxiety and depression, affecting quality of life.

Machine learning can use blood tests to help predict moderate-to-severe alopecia areata.

Sequential therapy with dupilumab and baricitinib improved hair regrowth and atopic dermatitis in a child without adverse reactions.

Brepocitinib 30mg is most effective for moderate-to-severe alopecia areata, but ritlecitinib 50mg may offer a better balance of safety and effectiveness.

Topical corticosteroids may be a safe and effective treatment for severe alopecia areata in children.

The study identified key immune cell differences between mild and severe alopecia areata.